Sanofi Pompe drug shortage forces patients to miss infusions: 6 notes

A shortage of Sanofi’s Pompe disease therapies Lumizyme and Nexviazyme has lasted more than three months, and some U.S. patients are having infusions canceled, according to a Nov. 19 CNBC report. Here are six things to know: The post Sanofi Pompe drug shortage forces patients to miss infusions: 6 notes appeared first on Becker's Hospital Review | Healthcare News & Analysis.

Original Source

Read the full article at Beckershospitalreview →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.